IP Verse

Merus N.v. competitive analysis

Latest oppositions filed by Merus N.v.

Explore patent oppositions filed by Merus N.v. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2786657
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 7, 2018
EP2787075
Rodent Capable Of Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant RegionsREGENERON PHARMACEUTICALSAug 30, 2017
EP2505654
Common Light Chain MouseREGENERON PHARMACEUTICALSMay 24, 2017
EP2701499
Non-Human Animals Expressing Antibodies Having A Common Light ChainREGENERON PHARMACEUTICALSNov 10, 2016
EP2264163
Methods Of Modifying Eukaryotic CellsREGENERON PHARMACEUTICALSJul 8, 2016
EP2501817
Common Light Chain MouseREGENERON PHARMACEUTICALSMay 25, 2016

Latest patents of Merus N.v. opposed by its competitors

Explore Merus N.v.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3456192
Sep 3, 2025Antibody Producing Non-Human Mammals1
EP3456190
Nov 24, 2021Antibody Producing Non-Human Mammals1
EP2604625
Jun 28, 2017Generation Of Binding Molecules2

Latest PTAB cases involving Merus N.v.

Discover the latest PTAB cases involving Merus N.v., highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 30, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merus N.v.

IPR2025-00604Feb 11, 2025XENCORMERUS N.V., KYMAB LIMITEDTerminated-Settled
IPR2025-00605Feb 11, 2025XENCORMERUS N.V., KYMAB LIMITEDTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Merus N.v. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERUS54 - 2
KYMAB1220 - 5
PEAK, JOANNA CAROLINE1 - - -
REGENERON PHARMACEUTICALS55153932